Director/PDMR Shareholding

RNS Number : 0598Y
AstraZeneca PLC
26 August 2009
 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4


We hereby inform you that on 25 August 2009 the interest of Lynn Tetrault, a person discharging managerial responsibilities, in AstraZeneca American Depositary Shares (ADSs) has changed as detailed below. One ADS equals one Ordinary Share. The change in interest relates to the vesting of an award made in August under the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, Lynn Tetrault has now become beneficially entitled to a percentage of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In addition, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.


Name

Number of Shares Awarded

Vesting Percentage

Number of Shares Lapsed

Number of Shares Vested

Number of Shares Withheld

Net Number of Shares


Lynn Tetrault


1,522


75%


380


1,142


371


771


The closing market price of AstraZeneca ADSs on 24 August 2009 was $46.16.


A C N Kemp

Company Secretary

26 August 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNSSRKKRWUAR

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings